Effect of Arginine Vasopressin on Intraoperative Hypotension Caused by Oral Administration of 5-Aminolevulinic Acid

5-Aminolevulinic acid (5-ALA) is used for the photodynamic diagnosis of malignant tumors and has been effectively utilized to improve the complete resection rate and reduce the risk of tumor recurrence. However, intraoperative hypotension is a common adverse effect of oral 5-ALA, and it occasionally...

Full description

Bibliographic Details
Main Authors: Gen Owada, Hideo Nishizawa, Yuki Matoyama, Eri Watanabe, Keigo Mitsuda, Naoki Kaneko, Yasuhiro Kimura, Taikan Nanao, Junichi Fujimoto
Format: Article
Language:English
Published: Hindawi Limited 2023-01-01
Series:Case Reports in Anesthesiology
Online Access:http://dx.doi.org/10.1155/2023/1745373
_version_ 1797827847559053312
author Gen Owada
Hideo Nishizawa
Yuki Matoyama
Eri Watanabe
Keigo Mitsuda
Naoki Kaneko
Yasuhiro Kimura
Taikan Nanao
Junichi Fujimoto
author_facet Gen Owada
Hideo Nishizawa
Yuki Matoyama
Eri Watanabe
Keigo Mitsuda
Naoki Kaneko
Yasuhiro Kimura
Taikan Nanao
Junichi Fujimoto
author_sort Gen Owada
collection DOAJ
description 5-Aminolevulinic acid (5-ALA) is used for the photodynamic diagnosis of malignant tumors and has been effectively utilized to improve the complete resection rate and reduce the risk of tumor recurrence. However, intraoperative hypotension is a common adverse effect of oral 5-ALA, and it occasionally progresses to severe prolonged hypotension requiring high-dose catecholamine administration. We report a case of intraoperative hypotension due to oral 5-ALA in which arginine vasopressin (AVP) administration was effective for increasing the blood pressure. A 77-year-old man scheduled for a craniotomy for glioma was administered 5-ALA orally before surgery. After the induction of anesthesia, his blood pressure decreased substantially. Although we administered various vasopressor agents, hypotension was prolonged. However, after starting a continuous administration of AVP, the systolic blood pressure increased, and the hemodynamic parameters remained stable during the remainder of the operation. 5-ALA administration may lower blood pressure by inducing nitric oxide production, and AVP inhibits inducible nitric oxide synthase messenger RNA expression and interleukin-1β-stimulated nitric oxide production. In light of these mechanisms, AVP may be a reasonable treatment agent for hypotension induced by 5-ALA.
first_indexed 2024-04-09T12:54:55Z
format Article
id doaj.art-7f5abf620624482eb5304fcce08cdfe3
institution Directory Open Access Journal
issn 2090-6390
language English
last_indexed 2024-04-09T12:54:55Z
publishDate 2023-01-01
publisher Hindawi Limited
record_format Article
series Case Reports in Anesthesiology
spelling doaj.art-7f5abf620624482eb5304fcce08cdfe32023-05-14T00:00:01ZengHindawi LimitedCase Reports in Anesthesiology2090-63902023-01-01202310.1155/2023/1745373Effect of Arginine Vasopressin on Intraoperative Hypotension Caused by Oral Administration of 5-Aminolevulinic AcidGen Owada0Hideo Nishizawa1Yuki Matoyama2Eri Watanabe3Keigo Mitsuda4Naoki Kaneko5Yasuhiro Kimura6Taikan Nanao7Junichi Fujimoto8Department of Intensive Care MedicineDepartment of Intensive Care MedicineDepartment of Intensive Care MedicineDepartment of Intensive Care MedicineDepartment of AnesthesiaDepartment of Intensive Care MedicineDepartment of Intensive Care MedicineDepartment of Intensive Care MedicineDepartment of Intensive Care Medicine5-Aminolevulinic acid (5-ALA) is used for the photodynamic diagnosis of malignant tumors and has been effectively utilized to improve the complete resection rate and reduce the risk of tumor recurrence. However, intraoperative hypotension is a common adverse effect of oral 5-ALA, and it occasionally progresses to severe prolonged hypotension requiring high-dose catecholamine administration. We report a case of intraoperative hypotension due to oral 5-ALA in which arginine vasopressin (AVP) administration was effective for increasing the blood pressure. A 77-year-old man scheduled for a craniotomy for glioma was administered 5-ALA orally before surgery. After the induction of anesthesia, his blood pressure decreased substantially. Although we administered various vasopressor agents, hypotension was prolonged. However, after starting a continuous administration of AVP, the systolic blood pressure increased, and the hemodynamic parameters remained stable during the remainder of the operation. 5-ALA administration may lower blood pressure by inducing nitric oxide production, and AVP inhibits inducible nitric oxide synthase messenger RNA expression and interleukin-1β-stimulated nitric oxide production. In light of these mechanisms, AVP may be a reasonable treatment agent for hypotension induced by 5-ALA.http://dx.doi.org/10.1155/2023/1745373
spellingShingle Gen Owada
Hideo Nishizawa
Yuki Matoyama
Eri Watanabe
Keigo Mitsuda
Naoki Kaneko
Yasuhiro Kimura
Taikan Nanao
Junichi Fujimoto
Effect of Arginine Vasopressin on Intraoperative Hypotension Caused by Oral Administration of 5-Aminolevulinic Acid
Case Reports in Anesthesiology
title Effect of Arginine Vasopressin on Intraoperative Hypotension Caused by Oral Administration of 5-Aminolevulinic Acid
title_full Effect of Arginine Vasopressin on Intraoperative Hypotension Caused by Oral Administration of 5-Aminolevulinic Acid
title_fullStr Effect of Arginine Vasopressin on Intraoperative Hypotension Caused by Oral Administration of 5-Aminolevulinic Acid
title_full_unstemmed Effect of Arginine Vasopressin on Intraoperative Hypotension Caused by Oral Administration of 5-Aminolevulinic Acid
title_short Effect of Arginine Vasopressin on Intraoperative Hypotension Caused by Oral Administration of 5-Aminolevulinic Acid
title_sort effect of arginine vasopressin on intraoperative hypotension caused by oral administration of 5 aminolevulinic acid
url http://dx.doi.org/10.1155/2023/1745373
work_keys_str_mv AT genowada effectofargininevasopressinonintraoperativehypotensioncausedbyoraladministrationof5aminolevulinicacid
AT hideonishizawa effectofargininevasopressinonintraoperativehypotensioncausedbyoraladministrationof5aminolevulinicacid
AT yukimatoyama effectofargininevasopressinonintraoperativehypotensioncausedbyoraladministrationof5aminolevulinicacid
AT eriwatanabe effectofargininevasopressinonintraoperativehypotensioncausedbyoraladministrationof5aminolevulinicacid
AT keigomitsuda effectofargininevasopressinonintraoperativehypotensioncausedbyoraladministrationof5aminolevulinicacid
AT naokikaneko effectofargininevasopressinonintraoperativehypotensioncausedbyoraladministrationof5aminolevulinicacid
AT yasuhirokimura effectofargininevasopressinonintraoperativehypotensioncausedbyoraladministrationof5aminolevulinicacid
AT taikannanao effectofargininevasopressinonintraoperativehypotensioncausedbyoraladministrationof5aminolevulinicacid
AT junichifujimoto effectofargininevasopressinonintraoperativehypotensioncausedbyoraladministrationof5aminolevulinicacid